225 related articles for article (PubMed ID: 2055358)
1. A novel tertiary pyridostigmine derivative [3-(N,N-dimethylcarbamyloxy)-1-methyl-delta 3-tetrahydropyridine]: anticholinesterase properties and efficacy against soman.
Ray R; Clark OE; Ford KW; Knight KR; Harris LW; Broomfield CA
Fundam Appl Toxicol; 1991 Feb; 16(2):267-74. PubMed ID: 2055358
[TBL] [Abstract][Full Text] [Related]
2. Effect of carboxylesterase inhibition on carbamate protection against soman toxicity.
Maxwell DM; Brecht KM; Lenz DE; O'Neill BL
J Pharmacol Exp Ther; 1988 Sep; 246(3):986-91. PubMed ID: 3418520
[TBL] [Abstract][Full Text] [Related]
3. Protection of guinea pigs against soman poisoning by pretreatment with p-nitrophenyl phosphoramidates.
Langenberg JP; De Jong LP; Benschop HP
Toxicol Appl Pharmacol; 1996 Oct; 140(2):444-50. PubMed ID: 8887462
[TBL] [Abstract][Full Text] [Related]
4. The effect of pyridostigmine pretreatment on oxime efficacy against intoxication by soman or VX in rats.
Anderson DR; Harris LW; Woodard CL; Lennox WJ
Drug Chem Toxicol; 1992; 15(4):285-94. PubMed ID: 1459041
[TBL] [Abstract][Full Text] [Related]
5. [Prevention and treatment of status epilepticus induced by soman].
Blanchet G; Carpentier P; Lallement G; Sentenac-Roumanou H
Ann Pharm Fr; 1994; 52(1):11-24. PubMed ID: 8085742
[TBL] [Abstract][Full Text] [Related]
6. Comparison of antidote protection against soman by pyridostigmine, HI-6 and acetylcholinesterase.
Maxwell DM; Brecht KM; Doctor BP; Wolfe AD
J Pharmacol Exp Ther; 1993 Mar; 264(3):1085-9. PubMed ID: 8450452
[TBL] [Abstract][Full Text] [Related]
7. Effect of endogenous carboxylesterase on HI-6 protection against soman toxicity.
Maxwell DM; Koplovitz I
J Pharmacol Exp Ther; 1990 Aug; 254(2):440-4. PubMed ID: 2384881
[TBL] [Abstract][Full Text] [Related]
8. Heat stress, even extreme, does not induce penetration of pyridostigmine into the brain of guinea pigs.
Lallement G; Foquin A; Baubichon D; Burckhart MF; Carpentier P; Canini F
Neurotoxicology; 1998 Dec; 19(6):759-66. PubMed ID: 9863765
[TBL] [Abstract][Full Text] [Related]
9. Protection by pyridostigmine bromide of marmoset hemi-diaphragm acetylcholinesterase activity after soman exposure.
Haigh JR; Adler M; Apland JP; Deshpande SS; Barham CB; Desmond P; Koplovitz I; Lenz DE; Gordon RK
Chem Biol Interact; 2010 Sep; 187(1-3):416-20. PubMed ID: 20144889
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of oral pyridostigmine pretreatment and cholinolytic-oxime therapy against soman intoxication in nonhuman primates.
von Bredow JD; Adams NL; Groff WA; Vick JA
Fundam Appl Toxicol; 1991 Nov; 17(4):761-70. PubMed ID: 1778362
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of antidotal effects of adamantyl derivative Tamorf in soman poisoning.
Lucić Vrdoljak A; Radić B; Garaj-Vrhovac V; Kopjar N; Zlender V
J Appl Toxicol; 2006; 26(1):56-63. PubMed ID: 16167315
[TBL] [Abstract][Full Text] [Related]
12. Effects of subchronic pyridostigmine pretreatment on the toxicity of soman.
Shiloff JD; Clement JG
Can J Physiol Pharmacol; 1986 Jul; 64(7):1047-9. PubMed ID: 3768795
[TBL] [Abstract][Full Text] [Related]
13. Carbamoylated enzyme reversal as a means of predicting pyridostigmine protection against soman.
Ellin RI; Kaminskis A
J Pharm Pharmacol; 1989 Sep; 41(9):633-6. PubMed ID: 2573709
[TBL] [Abstract][Full Text] [Related]
14. Relationship between reversible acetylcholinesterase inhibition and efficacy against soman lethality.
Lennox WJ; Harris LW; Talbot BG; Anderson DR
Life Sci; 1985 Sep; 37(9):793-8. PubMed ID: 4033355
[TBL] [Abstract][Full Text] [Related]
15. Acetylcholinesterase inhibition by (+)physostigmine and efficacy against lethality induced by soman.
Harris LW; Anderson DR; Pastelak AM; Vanderpool B
Drug Chem Toxicol; 1990; 13(2-3):241-8. PubMed ID: 2276342
[TBL] [Abstract][Full Text] [Related]
16. A combination of [+] and [-]-Huperzine A improves protection against soman toxicity compared to [+]-Huperzine A in guinea pigs.
Wang Y; Wei Y; Oguntayo S; Doctor BP; Nambiar MP
Chem Biol Interact; 2013 Mar; 203(1):120-4. PubMed ID: 23123250
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of huperzine in preventing soman-induced seizures, neuropathological changes and lethality.
Lallement G; Veyret J; Masqueliez C; Aubriot S; Burckhart MF; Baubichon D
Fundam Clin Pharmacol; 1997; 11(5):387-94. PubMed ID: 9342591
[TBL] [Abstract][Full Text] [Related]
18. [The effect of pharmacologic prophylaxis with Panpal on acetylcholinesterase activity in the diaphragm and various parts of the brain in rats during treated and untreated Soman poisoning].
Kassa J
Cas Lek Cesk; 1998 May; 137(10):299-302. PubMed ID: 9650360
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of alpha 2-adrenergic receptor stimulation in reducing the central toxicity following cholinesterase inhibition.
Buccafusco JJ; Li W
Res Commun Chem Pathol Pharmacol; 1992 Jan; 75(1):85-98. PubMed ID: 1352646
[TBL] [Abstract][Full Text] [Related]
20. Anticonvulsant and antilethal effects of the phencyclidine derivative TCP in soman poisoning.
Carpentier P; Foquin-Tarricone A; Bodjarian N; Rondouin G; Lerner-Natoli M; Kamenka JM; Blanchet G; Denoyer M; Lallement G
Neurotoxicology; 1994; 15(4):837-51. PubMed ID: 7715855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
